Literature DB >> 11407949

Autochthonous mouse models for prostate cancer: past, present and future.

W J Huss1, L A Maddison, N M Greenberg.   

Abstract

Prostate cancer continues to be the second leading cancer related death among men. In order to more fully develop effective prevention and intervention strategies for this prevalent disease, the underlying molecular mechanisms of initiation, progression and metastatic spread must be understood. To this end mouse models have an essential role in prostate cancer research in that they can closely mimic the pathological and biochemical features of the disease. In this review we discuss the history of autochthonous murine models of prostate cancer, the essentials of the idealized mouse model for prostate cancer and speculate on approaches towards this goal. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11407949     DOI: 10.1006/scbi.2001.0373

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  19 in total

Review 1.  Animal models of bone metastasis.

Authors:  Thomas J Rosol; Sarah H Tannehill-Gregg; Stephanie Corn; Abraham Schneider; Laurie K McCauley
Journal:  Cancer Treat Res       Date:  2004

2.  Application of Gleason analogous grading system and flow cytometry DNA analysis in a novel knock-in mouse prostate cancer model.

Authors:  G Wu; Lei Yu; L Wang; H Wang; J W Xuan
Journal:  Postgrad Med J       Date:  2006-01       Impact factor: 2.401

3.  Pre-clinical mouse models of human prostate cancer and their utility in drug discovery.

Authors:  Serk In Park; Sun Jin Kim; Laurie K McCauley; Gary E Gallick
Journal:  Curr Protoc Pharmacol       Date:  2010-12

4.  Conditional expression of human 15-lipoxygenase-1 in mouse prostate induces prostatic intraepithelial neoplasia: the FLiMP mouse model.

Authors:  Uddhav P Kelavkar; Anil V Parwani; Scott B Shappell; W David Martin
Journal:  Neoplasia       Date:  2006-06       Impact factor: 5.715

5.  Dissociation of epithelial and neuroendocrine carcinoma lineages in the transgenic adenocarcinoma of mouse prostate model of prostate cancer.

Authors:  Teresa Chiaverotti; Suzana S Couto; Annemarie Donjacour; Jian-Hua Mao; Hiroki Nagase; Robert D Cardiff; Gerald R Cunha; Allan Balmain
Journal:  Am J Pathol       Date:  2007-12-21       Impact factor: 4.307

6.  Molecular profiling of angiogenesis markers.

Authors:  Shu-Ching Shih; Gregory S Robinson; Carole A Perruzzi; Alfonso Calvo; Kartiki Desai; Jeffery E Green; Iqbal U Ali; Lois E H Smith; Donald R Senger
Journal:  Am J Pathol       Date:  2002-07       Impact factor: 4.307

7.  Tumor recognition and self-recognition induce distinct transcriptional profiles in antigen-specific CD4 T cells.

Authors:  Derese Getnet; Charles H Maris; Edward L Hipkiss; Joseph F Grosso; Timothy J Harris; Hung-Rong Yen; Tullia C Bruno; Satoshi Wada; Adam Adler; Robert W Georgantas; Chunfa Jie; Monica V Goldberg; Drew M Pardoll; Charles G Drake
Journal:  J Immunol       Date:  2009-04-15       Impact factor: 5.422

8.  Analysis of TMEFF2 allografts and transgenic mouse models reveals roles in prostate regeneration and cancer.

Authors:  Joshua M Corbin; Ryan F Overcash; Jonathan D Wren; Anita Coburn; Greg J Tipton; Jennifer A Ezzell; Kirk K McNaughton; Kar-Ming Fung; Stanley D Kosanke; Maria J Ruiz-Echevarria
Journal:  Prostate       Date:  2015-09-29       Impact factor: 4.104

9.  Cyclophosphamide augments antitumor immunity: studies in an autochthonous prostate cancer model.

Authors:  Satoshi Wada; Kiyoshi Yoshimura; Edward L Hipkiss; Tim J Harris; Hung-Rong Yen; Monica V Goldberg; Joseph F Grosso; Derese Getnet; Angelo M Demarzo; George J Netto; Robert Anders; Drew M Pardoll; Charles G Drake
Journal:  Cancer Res       Date:  2009-05-12       Impact factor: 12.701

10.  Age-related histopathological lesions in the Mongolian gerbil ventral prostate as a good model for studies of spontaneous hormone-related disorders.

Authors:  Silvana Gisele Pegorin Campos; Cristiani Zanetoni; Wellerson Rodrigo Scarano; Patrícia Simone Leite Vilamaior; Sebastião Roberto Taboga
Journal:  Int J Exp Pathol       Date:  2008-02       Impact factor: 1.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.